Clinical Liver Disease
Drug resistance: Prevalence and clinical implications during the treatment of chronic hepatitis C infection, Jean-Michel Pawlotsky - Article Reading
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:34
- Mas informaciones
Informações:
Sinopsis
The recent development of direct-acting antiviral (DAA) molecules that are active on hepatitis C virus (HCV) has raised the concern that resistance may undermine therapy based on DAAs.
